Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3030-3037

  Xie, Kevin Chunxi ^a   Plunkett, William ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOFARABINE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE TRIPHOSPHATE; DEOXYGUANOSINE TRIPHOSPHATE; DEOXYRIBONUCLEOTIDE; DNA; DNA POLYMERASE; GUANOSINE DIPHOSPHATE; NUCLEOSIDE ANALOG; RIBONUCLEOTIDE REDUCTASE; THYMIDINE; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL;

ADENINE NUCLEOTIDES; ANTIMETABOLITES, ANTINEOPLASTIC; ARABINONUCLEOSIDES; BASE SEQUENCE; CELL LINE; DNA; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOTIDES; RIBONUCLEOTIDE REDUCTASES; T-LYMPHOCYTES;

EID: 0029927229     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Secrist, J A., III, Shortnacy, A. T , and Montgomery, J A. Synthesis and biological evaluations of certain 2-halo-2′-substituted derivatives of 9-β-D-arabinofuranosyladenine. J Med Chem., 31: 405-410, 1988
2. Carson, D. A., Wasson, D B , Esparza, L M., Carrera, C. J., Kipps, T. J., and Cottam, H B Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabinofluoro-2′ deoxadenosine. Proc. Natl. Acad. Sci USA, 89. 2970-2974, 1992.
3. Waud, W. R. Schmid, S. M., Harrison, S D., Jr., Secrist, J. A., III, and Montgomery, J. A. Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine Proc. Am Assoc Cancer Res., 33 545, 1992.
4. Montgomery, J A , Shortnacy-Power, A. T., Clayton, S D , Riordan, J. M., and Secrist, J. A., III. Synthesis and biologic activity of 2′-fiuoro-2-halo derivatives of 9-β-D-arabinofuranosyladenine. J. Med. Chem., 35. 397-401, 1992
5. Simon, L. N., Bauer, R. J , Tolman, R L., and Robins, R K. Calf intestine adenosine deaminase. Substrate specificity. Biochemistry, 9: 573-577, 1970
6. Huang, P , and Plunkett, W. Phosphorolytic cleavage of 2-fluoroadenine from 9-β-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. Biochem. Pharmacol , 36: 2945-2950, 1987.
7. Albertioni, F., Hassan, M., Sillerring, J., and Liliemark, J. Kinetics of 2-chloro-2′-deoxyadenosine and 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine in isolated perfused rat liver Eur. J. Drug Metab Pharmacokinet., 20. 225-232, 1995.
8. Qian, M , Wang, X., Shanmuganathan, K., Chu, C. K., and Gallo, J. M. Pharmacokinetics of the anticancer agent 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosy-1)adenine in rats. Cancer Chemother. Pharmacol., 33: 484-488, 1994.
9. King, K M., and Cass, C E Membrane transport of 2-chloro-2′-deoxyadenosine and 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine is required for cytotoxicity Proc. Am Assn. Cancer Res., 35: 577, 1994.
10. Parker, W B., Shaddix, C. C., Chang, C. H., White, E L , Rose, L. M., Brockman, R. W , Shortnacy, A. T., Montgomery, J. A., Secrist, J. A., III, and Bennett, L. L., Jr. Effects of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5′-triphosphate. Cancer Res., 51 2386-2394, 1991.
11. Xie, C , and Plunkett, W Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine in human lymphoblastoid cells. Cancer Res , 55. 2847-2852, 1995.
12. Thelander, L., and Reichard, P Reduction of ribonucleotides. Annu. Rev Biochem., 48: 133-158, 1979.
13. Reichard, P Interactions between deoxyribonucleotide and DNA synthesis. Annu. Rev Biochem , 57: 349-374, 1988
14. Xie, C., and Plunkett, W. Inhibition of DNA synthesis in CCRF-CEM cells by 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine Proc Am Assn Cancer Res., 33: 512, 1992.
15. Ludwig, J A simple one flask synthesis of nucleoside 5′-triphosphates from unprotected nucleosides via nucleoside 5′-cyclotriphosphates. In. K S Bruzik and W J. Stec (eds ), Biophosphates and Their Analogues: Synthesis, Structure, Metabolism and Activity. Proceedings of the 2nd International Symposium on Phosphorus Chemistry Directed Towards Biology, pp. 201-204 Amsterdam: Elsevier Science Publishers B. V., 1987
16. Huang, P , Chubb, S., and Plunkett, W. Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine: a mechanism for cytotoxicity J Biol Chem , 265: 16617-16625, 1990.
17. Heinemann, V , Xu, Y-Z., Chubb, S., Sen, A., Hertel, L. W., Grindey, G. B., and Plunkett, W Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol Pharmacol , 38: 567-572, 1990.
18. Sherman, P., and Fyfe, J A. Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers Anal. Biochem., 180: 222-226, 1989
19. Sanger, F , Nicklen, S , and Coulson, A. R DNA sequencing with chain-terminating inhibitors Proc. Natl. Acad. Sci USA, 74: 5463-5467, 1977
20. Sheaff, R., Ilsley, D., and Kuchta, R The mechanism of DNA polymerase α inhibition by aphidicolin. Biochemistry, 30. 8590-8597, 1991
21. Reichard, P , and Eherenberg, A Ribonucleotide reductase - a radical enzyme. Science (Washington DC), 221: 514-519, 1983.
22. Fry, M., and Loeb, L A. Animal Cell DNA Polymerases. pp. 156-183. Boca Raton, FL. CRC Press, 1986
23. Lee, S-H., Pan, Z-Q., Kwong, A. D , Burgers, P. M. J., and Hurwitz, J. Synthesis of DNA by DNA polymerase ε in vitro. J. Biol. Chem., 266. 22707-22717, 1991
24. Bambara, R A , and Jessee, C. B Properties of DNA polymerases δ and ε, and their roles in eukaryotic DNA replication Biochim. Biophys. Acta, 1088: 11-24, 1991
25. So, A G., and Downey, K M. Eukaryotic DNA replication. Crit. Rev. Biochem Mol Biol., 27: 129-155, 1992.
26. Eriksson, S., Graslund, A , Skog, S , Thelander, L , and Tribukait, B. Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J. Biol Chem., 259 11695-11700, 1984.
27. Xu, Y-Z., Huang, P , and Plunkett, W Functional compartmentation of dCTP pools. Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts. J. Biol Chem , 270: 631-637, 1995
28. Griffig, J , Koob, R., and Blakley, R L. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res., 49: 6923-6928, 1989.
29. Plunkett, W., and Saunders, P P. Metabolism and action of purine nucleoside analogs Pharmacol. Ther , 49: 239-268, 1991.
30. Baker, C. H., Banzon, J , Bollinger, J. M , Stubbe, J., Samano, V., Robins, M. J., Lippert, B., Jarvi, E , and Resvick, R. 2′-Deoxy-2′-difluorodeoxycytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphates, potent mechanism-based inhibitors of ribonucleotide reductase. J. Med. Chem., 34: 1879-1884, 1991.
31. Keating, M. J , O'Brien, S , Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M , and Freireich, E J Long-term follow-up of patients with chrome lymphocytic leukemia treated with fludarabine as a single agent Blood. 81 2878-2884, 1993
32. Tallman, M. S., and Hakimian, D. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood. 86: 2463-2474, 1995
33. Saven, A , and Piro, L. D 2-Chlorodeoxyadenosine a newer purine analog active in the treatment of indolent lymphoid malignancies. Ann Intern. Med., 120: 784-791. 1994.
34. Kaye, S. B Gemcitabine: current status of phase I and phase II trials. J. Clin Oncol., 12: 1527-1531, 1994.
35. Plunkett, W , Gandhi, V., Huang, P., Robertson, L. E , Yang, L-Y, Gregoire, V , Estey, E., and Keating, M. J. Fludarabine pharmacokinetics, mechanisms of action, and rationales for combination therapies Semin Oncol , 20 (Suppl.7): 2-12, 1993
36. Plunkett, W , Huang, P , Xu, Y-Z, Heinemann, V., Grunewald, R., and Gandhi, V Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol., 22 (Suppl. 11): 3-10, 1995
37. Plunkett, W., and Gandhi, V. Pharmacokinetics of arabinosylcytosine. J. Infus Chemother., 2: 169-176, 1992
38. Gandhi, V., and Plunkett, W. Modulatory activity of 2′,2′-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides Cancer Res., 50: 3675-3680, 1990
39. Gandhi, V , Estey, E , Keating, M. J , and Plunkett, W Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J. Clin. Oncol., 11. 116-124, 1993
40. Gandhi, V., Estey, E , Keating, M. J., Chucrallah, A., and Plunkett, W Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions. Blood, 87: 256-264, 1996.
41. Yang, L-Y., Li, L , Keating, M J , and Plunkett, W. Arabinosyl-2-fluoroaderine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. Mol Pharmacol , 47. 1072-1079, 1995.
42. Gregoire, V., Hunter, N., Milas, L., Brock, W. A., Plunkett, W., and Hittelman, W. N Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine Cancer Res , 54: 468-474, 1994.
43. Shewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W., and Lawrence, T. S. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res., 54: 3218-3223, 1994.